Head-to-head
CoreAge Rx vs FORM by GBY
CoreAge Rx and FORM by GBY both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxFORM by GBY
Ranked #118 · Grade C
Best for: A working parent who wants the option of a brand-name pen alongside compounded semaglutide/tirzepatide, and who will confirm turnaround time and state coverage directly before counting on either.
Visit FORM by GBYThe verdict
CoreAge Rx edges out FORM by GBY on the Rx-Readiness Score, 95 to 53 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
FORM by GBY is still a genuine option — flat, all-inclusive compounded pricing plus a real path to FDA-approved Wegovy — but no stated turnaround time, and state coverage is only documented for a handful of states, both real planning gaps for a working parent. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | FORM by GBY |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 53/100 · C |
| Overall rank | #1 | #118 |
| Semaglutide | $99/mo | $299/mo |
| Tirzepatide | $149/mo | $399/mo |
| Coverage | All 50 states | CA, MA, VT confirmed (RI pending); other states not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
FORM by GBY
Ranked #118 · Grade C
What we like
- Compounded semaglutide and tirzepatide both clearly all-inclusive at $299/$399
- A real path to FDA-approved Wegovy®, not compounded-only
- Dedicated pages per drug, not one vague weight-loss catch-all
The caveats
- No stated time-to-first-dose anywhere on the site
- The $95/mo Wegovy membership doesn't clearly itemize whether the drug's cost is included
- No company-wide state list — only three states named for one clinician
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and FORM by GBY against other providers on our shortlist.
Or browse the full comparison hub.